Guardant Health Inc. (gh 1.25 02/15/31)
13F holders, Q2 2026 (June 30)4holders −2
1new positions
3sold out
$136.54avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Guardant Health Inc. (gh 1.25 02/15/31) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 3 sold out. The largest holders were Boussard & Gavaudan Gestion Sas ($60.1M), Northwest & Ethical Investments L.P. ($566K) and Bank of New York Mellon Corp ($504K).
- Company
- Guardant Health Inc. (gh 1.25 02/15/31)
- CUSIP
- 40131MAD1
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $566K |
| Exits | 3 | $9.0M |
All 13F filers, Q1 2026 → Q2 2026: 225,000 shares bought and 3,265,725 shares sold, net −3,040,725 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Boussard & Gavaudan Gestion Sas | 7.31% | — | 23,950 | $60.1M |
| Northwest & Ethical Investments L.P. | 0.01% | New | 225,000 | $566K |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $504K |
| Oddo BHF Asset Management Sas | 0.01% | Reduce -76.5% | 47 | $119K |
"% of holder's portfolio" is GUARDANT HEALTH INC (GH 1.25 02/15/31)'s weight in each manager's 13F, not the share of Guardant Health Inc. (gh 1.25 02/15/31) the manager owns.